Castleman's disease
RecruitingStudy on Nintedanib for Adults with Unicentric Castleman Disease
Study on Nintedanib for Adults with Unicentric Castleman Disease
- Disease:Castleman's disease
- Substances:–
France- Participants:18–64 years · 65+ years
Rare diseases
Investigational molecules
Locations
Study on Nintedanib for Adults with Unicentric Castleman Disease
FranceStudy of Ropivacaine and Dexamethasone Injection for Acute Low Back Pain Relief: Testing the Effectiveness of Erector Spinae Muscle Block
FranceStudy on the Safety and Effects of Efpegerglucagon in Children Aged 2 and Older with Congenital Hyperinsulinism
GermanyStudy of personalized FOLFIRINOX drug combination dosing (fluorouracil, irinotecan, oxaliplatin, and calcium folinate) for patients with pancreatic cancer
The NetherlandsStudy of doxecitine and doxribtimine oral solution for adult patients with Thymidine Kinase 2 (TK2) Deficiency
SpainStudy on Norepinephrine for Improving Outcomes in Patients with Acute Progressive Stroke
FranceStudy Comparing Fluocinolone Acetonide and Dexamethasone Implants for Patients with Resistant Diabetic Macular Edema
FranceStudy on Reducing Anxiety in Children Undergoing Surgery: Comparing Midazolam and Tablet Distraction Techniques
BelgiumMRI Study with Hyperpolarized Pyruvate for Patients with Glioblastoma
DenmarkStudy on Long-term Safety of NVDX3 Implant for Patients with Distal Radius Fracture or Low-grade Degenerative Lumbar Spondylolisthesis
LuxembourgStudy on Mifamurtide with Chemotherapy for Patients with High-Risk Osteosarcoma
FranceStudy on Regorafenib for Patients with Recurrent Grade 2 and 3 Meningioma After Surgery and Radiotherapy
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.